# Night movers — Oct 14: Chip selloff deepens as healthcare takes the baton

_AI-generated trading idea · NEUTRAL · UNH, BMY, MRK, WMT, CVS, VNET, ORCL, AMD, LRCX, INTC_

> Canonical page: https://commonquant.ai/research/for-you/night-movers-oct-14-chip-selloff-deepens-as-healthcare-takes--9d3ee3b7-ef34-5be7-8899-fcdc729c2e75

After-midnight gainers were led by UNH up 4.73%, BMY up 4.61%, MRK up 3.80%, WMT up 3.46%, and CVS up 3.24%. Decliners were led by VNET down 14.64%, ORCL down 8.83%, AMD down 5.73%, LRCX down 4.71%, and INTC down 4.56% amid an ongoing chip selloff.

## Idea

\#\# Session overview
After-midnight gainers were led by UNH up 4.73%, BMY up 4.61%, MRK up 3.80%, WMT up 3.46%, and CVS up 3.24%. Decliners were led by VNET down 14.64%, ORCL down 8.83%, AMD down 5.73%, LRCX down 4.71%, and INTC down 4.56% amid an ongoing chip selloff.

\#\# Compared with previous session
The prior night's after-midnight gainers were led by ORCL up 4.23%, META up 2.63%, and NIO up 2.59%, while decliners were led by JNJ down 5.73%, C down 5.60%, and WFC down 3.10%. In a sharp reversal, ORCL and AMD flipped from the prior session's gainers to tonight's losers, and LRCX extended its slide from 2.73% down to 4.71%.

\#\# Gainers
\- \*\*UNH +4.73%\*\* — UNH rose 4.73% in after-midnight trading. No matching ingested catalyst was found for UNH, so the move is reported without news attribution.
\- \*\*BMY +4.61%\*\* — BMY gained 4.61% in after-midnight trading. No matching ingested catalyst was found for BMY, so the move is reported without news attribution.
\- \*\*MRK +3.80%\*\* — MRK advanced 3.80% in after-midnight trading. No matching ingested catalyst was found for MRK, so the move is reported without news attribution.
\- \*\*WMT +3.46%\*\* — WMT climbed 3.46% in after-midnight trading. No matching ingested catalyst was found for WMT, so the move is reported without news attribution.
\- \*\*CVS +3.24%\*\* — CVS added 3.24% in after-midnight trading. No matching ingested catalyst was found for CVS, so the move is reported without news attribution.

\#\# Losers
\- \*\*VNET -14.64%\*\* — VNET dropped 14.64% in after-midnight trading. No matching ingested catalyst was found for VNET, so the move is reported without news attribution.
\- \*\*ORCL -8.83%\*\* — ORCL fell 8.83% in after-midnight trading. No matching ingested catalyst was found for ORCL, so the move is reported without news attribution.
\- \*\*AMD -5.73%\*\* — AMD declined 5.73% in after-midnight trading. No matching ingested catalyst was found for AMD, so the move is reported without news attribution.
\- \*\*LRCX -4.71%\*\* — LRCX lost 4.71% in after-midnight trading. No matching ingested catalyst was found for LRCX, so the move is reported without news attribution.
\- \*\*INTC -4.56%\*\* — INTC slipped 4.56% amid a worldwide memory-chip stock tumble and an ongoing chip selloff as major-bank earnings begin, per Bloomberg. Julia Herrmann of New York Life Management said investor focus has shifted to concern that chip spending, after hyperscaler capex, could become so high it threatens free cash flow.

## Advanced Analysis

### Verdict: The Healthcare Long Is a Good Watch-List Idea — But It Hasn't Fired Yet

The strongest point for this idea is that the fundamentals of the five long candidates genuinely support a defensive rotation: BMY's Q2 free cash flow jumped 308% quarter over quarter to $3.1B with net income up 24%, CVS posted $5.7B of free cash flow (up 66.3%), and WMT grew revenue 5.9% sequentially to $186.1B — while the chip complex per Bloomberg is selling off on concern hyperscaler capex threatens free cash flow. The strongest point against is that the compiled entry conditions have never fired in 1,233 daily bars over 60 months, and no robust parameter setup was established, so this is a thesis-consistent watch-list waiting for its first trigger rather than a validated signal. The proximity picture is encouraging on the pullback half — CVS sits just 1.6 points above its 21-day average (90.39 vs 88.76) with positive momentum at +4.70, and MRK is only 3.2 points away — but BMY's confirmation leg (10-day momentum at negative 4.05 needing to turn positive) and the broad net insider selling across all ten names in the provisional September 30 ownership filings are real headwinds. The evidence gap that would flip this verdict is concrete: a daily close in CVS (or another candidate) at or below its 21-day average that reclaims it with positive momentum would convert the setup from watch-list to actionable. Until then, the discipline is to wait for the market to come to the levels rather than chase names that just moved 3-5%.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 68/100 |
| Trade readiness | 35/100 |
| Risk quality | 55/100 |
| Trigger proximity | 62/100 |
| Fundamentals trend | 70/100 |
| Score | 58/100 |
| Composite Score | 58/100 |
| Evidence Tier | rules\_not\_triggered |

#### Decision scenarios

Bull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.

| Measure | Value |
| --- | ---: |
| Evidence Tier | rules\_not\_triggered |

### Trade now: pullback levels mapped, but no entry is live

No entry triggered today and nothing should be chased. The setup is a defensive rotation long — UNH, BMY, MRK, WMT, and CVS — that buys either a pullback into the 21-day moving average or a first-support test that holds. As of the latest close, four of the five names sit above their 21-day average, so the pullback half of the setup has not been reached. UNH is the furthest away at 395.62 versus 380.35, about 15.3 points (3.9%) above the level; MRK is 3.2 points above (147.37 vs 144.12); WMT is 6.9 points above (116.16 vs 109.22); CVS is closest at 90.39 versus 88.76, just 1.6 points shy. BMY is the outlier: it already trades below its average (58.35 vs 60.58), but its 10-day momentum is at negative 4.05, so the confirmation leg — momentum turning positive — is the missing condition there.

What "wait" means concretely: for UNH, MRK, WMT, and CVS the trigger is a daily bar whose low touches or undercuts the 21-day average while the close reclaims it with positive momentum. For BMY it is the 10-day momentum moving above zero while price stays below its average. CVS could qualify within a session or two; UNH needs roughly a 4% fade first.

If an entry does fire, the risk is fixed in advance: a 2.5% stop against a 5.0% target, roughly 2-to-1 reward to risk, with per-name risk sized at 2.5% of the account and no position above 20% of capital. The time-based exit also applies if a position is still held after 45 trading days below the average.

On validation: the author requested bounded optimization of the compiled rules after zero historical triggers, keeping the symbols, long direction, exits, and risk rules intact — but no robust parameter setup was established, so the published thresholds should be treated as the live research levels, not a tuned system. The discipline for today is simply to let the market come to the levels.

#### UNH price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | UNH |
| Timeframe | 1d |

#### BMY price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | BMY |
| Timeframe | 1d |

#### MRK price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | MRK |
| Timeframe | 1d |

### Defensive Rotation Has Real Cash Flows Behind It

The session's message — healthcare taking the baton from a chip selloff, per the Bloomberg piece on rising rates and resilient growth — lands on names whose fundamentals can actually support a bid. UNH led gainers at +4.73% and just posted Q2 (period ended June 30, 2026) revenue of $112.0B, up 0.28% sequentially, with free cash flow of $10.3B, up 25.8% from Q1, and a debt-to-equity ratio that improved from 0.75 to 0.70. BMY added 4.61% on a much stronger quarter: revenue of $13.0B, up 12.9% sequentially, net income up 23.9% to $3.3B, and free cash flow of $3.1B versus $757M in Q1 — a 308% jump that speaks for itself. WMT (+3.46%) and CVS (+3.24%) round out the defensive trade with steady compounding: WMT grew revenue 5.93% sequentially to $186.1B with net income up 19.4%, while CVS posted a 5.65% sequential revenue increase and $5.7B of free cash flow, up 66.3%.

These five names also carry the kind of dividend records that reward patient longs. WMT's annual dividend has grown at 7.2% a year, CVS lifted its payout to $2.52 per share for 2026, and BMY pays $2.48 with recent quarterly payments of $0.63. If investors are rotating out of capex-heavy semis — the thesis notes concern, per Bloomberg, that chip spending could threaten free cash flow — the cash-generation contrast is stark: AMD's free cash flow fell 39.3% sequentially to $1.6B, and ORCL burned $5.4B of free cash flow in its latest quarter as AI infrastructure spending ramps.

On the technical side, the idea's own thesis is a support-and-reclaim long: pullback into the 21-day EMA or rank-1 support with a positive close and positive 10-day momentum across UNH, BMY, MRK, WMT, and CVS. That is a continuation entry into an uptrend, not a falling-knife bet. Note the evidence contract: the entry conditions did not trigger in the evaluated windows (1,233 daily bars over 60 months, plus 24- and 12-month checks), so this is a watch-list setup rather than an active, realized signal — there is no realized performance history for this idea to lean on here, only the rules themselves.

The unresolved question for readers is whether the healthcare bid has the legs to create the exact entry condition the rules require. The fundamentals above argue these names deserve a bid; the setup simply hasn't printed yet.

#### LRCX Free cash flow

Free cash flow trend from CommonQuant fundamentals/XBRL data; +158.1% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2009-06-28 | $-122411000 |
| 2009-09-27 | $-3128000 |
| 2009-12-27 | $66417000 |
| 2010-03-28 | $98443000 |
| 2010-06-27 | $315123000 |
| 2010-06-27 | $153391000 |
| 2010-09-26 | $236614000 |
| 2010-12-26 | $147558000 |
| 2011-03-27 | $205824000 |
| 2011-06-26 | $753533000 |
| 2011-06-26 | $163537000 |
| 2011-09-25 | $71168000 |
| Latest Value | $71168000 |
| Change Pct | $158.13856597854766 |
| Ticker | LRCX |
| Timeframe | reported periods |

#### AMD sector percentile check

Ranks AMD against 833 companies in its sector using CommonQuant fundamentals.

| Measure | Value |
| --- | ---: |
| Free cash flow | \98.79951980792316th percentile |
| Operating margin | \87.43047830923248th percentile |
| Revenue growth (YoY) | \85.42825361512793th percentile |
| Rnd Intensity | \65.69444444444444th percentile |
| Ticker | AMD |
| Sector | Information Technology |
| Peer Count | 833 |

#### BMY sector percentile check

Ranks BMY against 1019 companies in its sector using CommonQuant fundamentals.

| Measure | Value |
| --- | ---: |
| Free cash flow | \99.31305201177624th percentile |
| Revenue growth (YoY) | \36.47316538882803th percentile |
| Rnd Intensity | \38.544474393531th percentile |
| Gross margin | \58.29145728643216th percentile |
| Ticker | BMY |
| Sector | Health Care |
| Peer Count | 1019 |

### Zero Triggers, Insider Selling, and a Chip Contagion That Doesn't Respect Labels

Start with the most uncomfortable fact: this setup has never fired. The rules were evaluated on 1,233 daily bars over 60 months — and separately over 24- and 12-month windows — and produced zero entries on every pass. The optimization decision itself concedes the compiled conditions are so strict they must all hold on the same bar that the setup is 'unnecessarily strict' rather than rare. A bounded parameter search was requested, but the sensitivity evaluation exceeded its time budget and returned no recommended setup, so there is no validated parameter configuration to trade. This is a thesis without a realized track record, full stop.

Second, the ownership data cuts against every name in the basket. For the September 30, 2026 reporting period (provisional coverage), all five long candidates show net insider open-market selling: WMT insiders sold a net $1.06B, CVS $171.6M, UNH $660,910, BMY $437,248, and MRK $28.6M. Insiders at the decliners were selling too — AMD by $176.2M and ORCL by $45.0M — so the selling posture is not a rotation signal, it is a broad one.

Third, fundamentals are weaker than the tape suggests in two of the five names. UNH's Q4 2025 showed near-zero net income ($10M on $113.2B of revenue, a 0.009% net margin) and just $160M of free cash flow, and its latest Q2 net income actually fell 12.7% sequentially to $5.5B with net margin compressing from 5.6% to 4.9%. MRK — the third-ranked gainer at +3.80% — reported a net loss of $1.3B in its most recent quarter, albeit improved from a $4.2B loss in Q1, and its trailing dividend of $3.40 per share sits on an earnings base that has been negative for two straight quarters. CVS's net margin is a thin 2.8%.

Finally, the very catalyst that lifted healthcare is a risk overlay for the whole idea: Bloomberg reports a worldwide memory-chip tumble and ongoing chip selloff driven by concern that hyperscaler capex threatens free cash flow. VNET fell 14.6% despite posting a wider annual free-cash-flow loss of $820.5M in FY2025, INTC fell 4.6% after swinging to an $11.0B net loss with debt-to-equity jumping 42.8% sequentially, and ORCL fell 8.8% the night after gaining 4.2% — a reminder that in this tape, reversals are violent and one-session leadership is not a moat. If rate-driven risk-off deepens, the defensive bid itself can unwind.

#### Rule trigger diagnostic

The rule set was evaluated against real market bars but did not open an entry; use the watch triggers as the actionable read.

| Measure | Value |
| --- | ---: |
| Bars evaluated | 1233 count |
| Entries | 0 count |

#### ORCL Debt to equity

Debt to equity trend from CommonQuant fundamentals/XBRL data; +9680.1% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2015-05-31 | \0.8622156463843166 ratio |
| 2016-05-31 | \0.9273826894203724 ratio |
| 2017-05-31 | \1.0751763832157446 ratio |
| 2018-05-31 | \1.307232812904339 ratio |
| 2019-05-31 | \2.5782419095708056 ratio |
| 2020-05-31 | \5.929849262878913 ratio |
| 2021-05-31 | \16.083428789614356 ratio |
| 2023-05-31 | \84.32525629077354 ratio |
| Latest Value | \84.32525629077354 ratio |
| Change Pct | \9680.065653458012 ratio |
| Ticker | ORCL |
| Timeframe | reported periods |

#### VNET Return on equity

Return on equity trend from CommonQuant fundamentals/XBRL data; -6869.6% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2009-12-31 | \0.006096304932661528% |
| 2010-12-31 | \0.3077354084477852% |
| 2011-12-31 | \0.011159184046556268% |
| 2012-12-31 | \0.030098273961562925% |
| 2013-12-31 | \-0.019608181030408067% |
| 2014-12-31 | \-0.1581935861831988% |
| 2015-12-31 | \-0.10662564294518911% |
| 2016-12-31 | \-0.103440940440458% |
| 2017-12-31 | \-0.15302999307064633% |
| 2018-12-31 | \-0.04025454796006523% |
| 2019-12-31 | \-0.036801477512628855% |
| 2020-12-31 | \-0.4126982864867014% |
| Latest Value | \-0.4126982864867014% |
| Change Pct | \-6869.64638490492% |
| Ticker | VNET |
| Timeframe | reported periods |

### Company context

\#\#\# UNH \*\*Ownership and insiders.\*\* For the period ending 2026-09-30, 148 reporting holders were counted holding 1953704 reported shares. Insider filings indicate net open-market selling, netting US$-660910 Coverage: Provisional. \*\*Management.\*\* Mr. Stephen J. Hemsley is identified as chief executive. Mr. Stephen J. Hemsley is listed as CEO & Non-Independent Non-Executive Chairman, with reported total pay of US$1.3M for fiscal 2025. Source: \[Yahoo Finance quoteSummary\](https://finance.yahoo.com/quote/UNH/profile), retrieved 2026-10-15T04:06:11.03+00:00. \*\*Dividends.\*\* Trailing twelve-month distributions total USD 9.06 per share; the latest observed ex-date was 2026-09-14 at USD 2.32 per share. The latest annual comparison is +5.1%. Source: \[Yahoo Finance corporate actions\](https://finance.yahoo.com/quote/UNH/history?filter=div), retrieved 2026-10-15T04:06:11.03+00:00. \*\*Fundamental changes.\*\* Latest reported comparisons: - Debt to equity: 0.7x for Q2 ending 2026-06-30 versus 0.75x for Q1 ending 2026-03-31 (-6.5%) · quarter over quarter - Free cash flow: USD 10.3B for Q2 ending 2026-06-30 versus USD 8.1B for Q1 ending 2026-03-31 (+25.8%) · quarter over quarter - Gross margin: 88.0% for Q2 ending 2026-06-30 versus 88.5% for Q1 ending 2026-03-31 (-0.5 percentage points) · quarter over quarter - Net Income: USD 5.5B for Q2 ending 2026-06-30 versus USD 6.3B for Q1 ending 2026-03-31 (-12.7%) · quarter over quarter - Net margin: 4.8% for Q2 ending 2026-06-30 versus 5.6% for Q1 ending 2026-03-31 (-0.7 percentage points) · quarter over quarter - Operating Cash Flow: USD 11.1B for Q2 ending 2026-06-30 versus USD 8.9B for Q1 ending 2026-03-31 (+24.0%) · quarter over quarter - Operating margin: 7.1% for Q2 ending 2026-06-30 versus 8.0% for Q1 ending 2026-03-31 (-0.9 percentage points) · quarter over quarter - Revenue: USD 112.0B for Q2 ending 2026-06-30 versus USD 111.7B for Q1 ending 2026-03-31 (+0.3%) · quarter over quarter - Return on equity: 5.2% for Q2 ending 2026-06-30 versus 6.0% for Q1 ending 2026-03-31 (-0.8 percentage points) · quarter over quarter - Shares Outstanding: 905.0M shares for Q2 ending 2026-06-30 versus 908.0M shares for Q1 ending 2026-03-31 (-0.3%) · quarter over quarter Source: Reported company financial data. Comparisons use consecutive reported periods at the same cadence and compatible units. Relative percentage changes require a positive baseline; rate changes are expressed in percentage points. \#\#\# BMY \*\*Ownership and insiders.\*\* For the period ending 2026-09-30, 103 reporting holders were counted holding 4602232 reported shares. Insider filings indicate net open-market selling, netting US$-437247.93. Coverage: Provisional. \*\*Management.\*\* Dr. Christopher S. Boerner Ph.D. is identified as chief executive. Dr. Christopher S. Boerner Ph.D. is listed as CEO & Chairman, with reported total pay of US$5.8M for fiscal 2025. Source: \[Yahoo Finance quoteSummary\](https://finance.yahoo.com/quote/BMY/profile), retrieved 2026-10-15T04:06:11.03+00:00. \*\*Dividends.\*\* Trailing twelve-month distributions total USD 2.52 per share; the latest observed ex-date was 2026-10-02 at USD 0.63 per share. The latest annual comparison is +1.6%. Source: \[Yahoo Finance corporate actions\](https://finance.yahoo.com/quote/BMY/history?filter=div), retrieved 2026-10-15T04:06:11.03+00:00. \*\*Fundamental changes.\*\* Latest reported comparisons: - Debt to equity: 1.93x for Q2 ending 2026-06-30 versus 2.22x for Q1 ending 2026-03-31 (-12.8%) · quarter over quarter - Free cash flow: USD 3.1B for Q2 ending 2026-06-30 versus USD 757.0M for Q1 ending 2026-03-31 (+307.9%) · quarter over quarter - Gross margin: 71.2% for Q2 ending 2026-06-30 versus 70.2% for…

### Scores

- **Conviction score breakdown:** 58
- **Thesis support:** 68
- **Trade readiness:** 35
- **Risk quality:** 55
- **Trigger proximity:** 62
- **Fundamentals trend:** 70

### Watch items

- **CVS — Price vs 21-day EMA**
- **BMY — 10-day momentum**
- **MRK — Price vs 21-day EMA**
- **WMT — Price vs 21-day EMA**
- **UNH — Price vs 21-day EMA**
- **BMY — Q2 2026 free cash flow momentum**
- **MRK — Net income**
- **UNH — Decisive close vs 21-day EMA**

## Key details

- Symbols: UNH, BMY, MRK, WMT, CVS, VNET, ORCL, AMD, LRCX, INTC
- Timeframes: 1d
- Tags: \#daily-movers, \#market-moves

## Community

- Upvotes: 0
- Views: 6
- Copies: 0
- Cosigns: 0

## News sources

- [Resilient Growth Cushions Tech Amid Rising Rates](https://www.bloomberg.com/news/videos/2026-10-14/resilient-growth-cushions-tech-amid-rising-rates-video) — Bloomberg Markets

## Related

- [UNH trade ideas](https://commonquant.ai/markets/unh)
- [BMY trade ideas](https://commonquant.ai/markets/bmy)
- [MRK trade ideas](https://commonquant.ai/markets/mrk)
- [WMT trade ideas](https://commonquant.ai/markets/wmt)
- [CVS trade ideas](https://commonquant.ai/markets/cvs)
- [VNET trade ideas](https://commonquant.ai/markets/vnet)
- [ORCL trade ideas](https://commonquant.ai/markets/orcl)
- [AMD trade ideas](https://commonquant.ai/markets/amd)
- [LRCX trade ideas](https://commonquant.ai/markets/lrcx)
- [INTC trade ideas](https://commonquant.ai/markets/intc)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (over a timeframe-dependent historical window with walk-forward tuning) and stress-tested before they can go live, then monitored against the news hourly while they run.